Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Principles of Drug Action01:24

Principles of Drug Action

Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stereoselective design of amino acid bioconjugates: targeting strategies and physicochemical optimization.

RSC medicinal chemistry·2025
Same author

A Novel Benzoxaborole Is Active against Escherichia coli and Binds to FabI.

Antimicrobial agents and chemotherapy·2021
Same author

Incidence of spontaneous intestinal perforations exceeds necrotizing enterocolitis in extremely low birth weight infants fed an exclusive human milk-based diet: A single center experience.

Journal of pediatric surgery·2020
Same author

Implications of Population Screening for Thalassemias and Hemoglobinopathies in Rural Areas of West Bengal, India: Report of a 10-Year Study of 287,258 Cases.

Hemoglobin·2020
Same author

The relevance of persisters in tuberculosis drug discovery.

Microbiology (Reading, England)·2019
Same author

Testo and testo-Pt(II) bind DNA at different locations.

Chemico-biological interactions·2018

Related Experiment Video

Updated: Jun 19, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Rational drug design.

Soma Mandal1, Mee'nal Moudgil, Sanat K Mandal

  • 1Manitoba Institute of Cell Biology, University of Manitoba, 675 McDermot Avenue, Winnipeg, Manitoba, Canada R3E 0V9. sanat.mandal@cna.nl.ca

European Journal of Pharmacology
|October 20, 2009
PubMed
Summary
This summary is machine-generated.

Rational drug design integrates gene expression technology and bioinformatics to overcome toxic side effects and improve drug development efficiency. This multidisciplinary approach accelerates the creation of safer, more effective therapeutics.

Related Experiment Videos

Last Updated: Jun 19, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Area of Science:

  • Pharmacology and Bioinformatics
  • Drug Discovery and Development

Background:

  • Traditional target-based drug design often results in drugs with severe toxic side effects.
  • Drug development is inherently challenging, expensive, and time-consuming, despite advancements in computational tools.

Purpose of the Study:

  • To present an approach for rational drug design.
  • To highlight the necessity of a multidisciplinary strategy in modern drug discovery.

Main Methods:

  • Review of current drug design knowledge.
  • Integration of gene expression technology and bioinformatics tools into structure-based drug design.
  • Analysis of global gene expression data.

Main Results:

  • Gene expression data analysis offers efficiency, cost-effectiveness, and time savings.
  • Bioinformatics tools aid in identifying strategies for combination therapy.
  • Incorporating gene expression data is improving structure-based drug design outcomes.

Conclusions:

  • Rational drug design necessitates a multidisciplinary approach, combining computational chemistry and gene expression analysis.
  • The integration of gene expression data is transforming drug development, moving towards more successful drug outcomes.
  • Future development requires more sophisticated methodologies for enhanced drug discovery.